ClinicalTrials.govpublic full text
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
breast cancer, her2-positive, neoadjuvant, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 802822
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.